What is Evidently?
Founded in 2020 and headquartered in Palo Alto, California, Evidently specializes in cognitive AI platforms tailored for the healthcare industry. The company provides an AI-powered platform designed to automate critical tasks such as clinical documentation, research, and population health management. Evidently's technology functions as an AI resident, adept at synthesizing information from diverse sources, including external health records, and integrating seamlessly with existing electronic health record systems. Its solutions aim to enhance operational efficiency, improve documentation accuracy, and streamline healthcare workflows by automating clinical summarization, supporting clinical decision-making, and managing population health initiatives. Evidently serves a range of healthcare professionals, including clinicians, data abstractors, research teams, and care coordinators, with the overarching goal of improving patient care and reducing clinician burnout.
How much funding has Evidently raised?
Evidently has raised a total of $15M across 1 funding round:
Series A
$15M
Series A (2024): $15M with participation from DN Capital, Clear Ventures, and Fellows Fund
Key Investors in Evidently
DN Capital
DN Capital is a global early-stage venture capital firm founded in 2000, focusing on Seed, Series A, and select Series B opportunities in Software, AI, Fintech, and Consumer Internet. They leverage their extensive network to support entrepreneurs in growing impactful businesses.
Clear Ventures
Clear Ventures is an early-stage venture capital firm that provides seed capital and operational insights to disruptive technology innovators, aiming to help them build impactful companies with a focus on significant market exits.
Fellows Fund
Fellows Fund reimagines AI and Web3.0 venture capital by leveraging a brain trust of Fellows who are leaders in cutting-edge research and C-level tech expertise to support early-stage AI companies.
What's next for Evidently?
With a recent Series A funding round of $15 million, Evidently is poised for significant expansion and further development of its AI-driven healthcare solutions. This major enterprise-level funding will likely be directed towards enhancing its cognitive AI platform, broadening its market reach, and potentially scaling its operations to meet the increasing demand for intelligent automation in healthcare. The strategic investment signals a strong belief in Evidently's capacity to transform healthcare workflows and improve patient outcomes through advanced technology. Future growth may involve deeper integration with healthcare systems, development of new AI functionalities, and strategic partnerships to accelerate adoption across the industry.
See full Evidently company page
